Machine Tools Market to Reach USD 189.44 Billion by 2032 Owing to Rapid Technological Advancements and Increased Automation Across Industries | Report by SNS Insider
October 16, 2024 03:14 ET
|
SNS Insider pvt ltd
Austin, Oct. 16, 2024 (GLOBE NEWSWIRE) -- The Machine Tools Market Share was estimated at USD 106.55 billion in 2023 and is expected to reach USD 189.44 billion by 2032 at a CAGR of 6.65% during the...
Vincerx Reports Positive Initial Clinical Data from Ongoing VIP943 Phase 1 Dose-Escalation Study and Provides Pipeline and Corporate Updates
October 07, 2024 16:05 ET
|
Vincerx Pharma, Inc.
VIP943 demonstrates promising safety and tolerability and achieves two complete responses to date in Phase 1 dose-escalation study, reinforcing the program’s potential and validating the VersAptx™...
Aerospace Valves Market to Reach $18.5 Billion, Globally, by 2033 at 4.2% CAGR: Allied Market Research
October 01, 2024 09:18 ET
|
Allied Analytics LLP
Wilmington, Delaware, Oct. 01, 2024 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, "Aerospace Valves Market by Type (Butterfly Valve, Ball Valve, Rotary Valve and Others),...
Vincerx Pharma Reports Second Quarter 2024 Financial Results
August 08, 2024 16:30 ET
|
Vincerx Pharma, Inc.
Vincerx continues to enroll its Phase 1 studies of antibody-drug conjugate (ADC) VIP943, with data expected by the end of Q4 2024, and small molecule drug-conjugate (SMDC) VIP236, with data expected...
Global Cooling Tower Market Report 2024-2029: Power Generation Segment and Asia-Pacific Accounted for Largest Shares of Cooling Tower Market in 2023
July 15, 2024 06:42 ET
|
Research and Markets
Dublin, July 15, 2024 (GLOBE NEWSWIRE) -- The "Global Cooling Tower Market by Type (Evaporative, Dry, Hybrid), Design (Natural, Mechanical), Construction Material (Concrete, Steel, FRP, Wood), Flow...
Cyclacel Announces Notice of Intention to Grant New European Patent Covering Plogosertib Pharmaceutical Compositions
June 26, 2024 09:15 ET
|
Cyclacel
NOTICE OF INTENTION TO GRANT OF NEW EUROPEAN PATENT
COVERING PLOGOSERTIB PHARMACEUTICAL COMPOSITIONS
- Lengthens Patent Exclusivity to August 2040
Basilea verpartnert Onkologie-Wirkstoffkandidat Lisavanbulin mit Glioblastoma Foundation
June 20, 2024 01:15 ET
|
Basilea Pharmaceutica AG
Allschwil, 20. Juni 2024 Basilea Pharmaceutica AG, Allschwil (SIX: BSLN), ein biopharmazeutisches Unternehmen mit bereits vermarkteten Produkten und dem Ziel, Patienten zu helfen, die an schweren...
Basilea partners oncology drug candidate lisavanbulin with Glioblastoma Foundation
June 20, 2024 01:15 ET
|
Basilea Pharmaceutica AG
Allschwil, Switzerland, June 20, 2024 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial...
Seeking Hope Amidst the Infertility Crisis: Vitaleon Pharma’s BGP-15 Molecule Promises a Better Future
June 06, 2024 16:56 ET
|
Vitaleon Pharma
Amsterdam, The Netherlands, June 06, 2024 (GLOBE NEWSWIRE) -- The demographic landscape is facing a significant challenge globally: fertility rates have been consistently below replacement levels...
Vincerx Pharma Reports First Quarter 2024 Financial Results and Provides Corporate Update
May 14, 2024 16:15 ET
|
Vincerx Pharma, Inc.
Vincerx continued to progress Phase 1 dose-escalation studies for VIP943, a potentially best-in-class anti-CD123 antibody-drug conjugate (ADC), and VIP236, a first-in-class small molecule-drug...